United State
English
For You
Latest
Interests
(0)
Settings
Block List
Following Tags
Explore Channels
Queens Chronicle
Follow
About:
Keeping up to date on the latest breaking news in Queens, nearby shopping and dining destinations.
Contact Us:
Tel: +1 718-205-8000 Email:mailbox@qchron.com
Club Offers for Travel Enthusiasts in Canada
Queens Chronicle
9 hrs ago
63
CGTN: How China's high-standard opening up fuels high
Queens Chronicle
11 hrs ago
8
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit
Queens Chronicle
16 hrs ago
31
Monumental Milestones at the 2025 CNO Financial Indianapolis Monumental Marathon
Queens Chronicle
17 hrs ago
140
Cindy Eckert, Founder and CEO of Sprout Pharmaceuticals, to Keynote Harvard Business School's 2025 Women's Health Summit
Queens Chronicle
23 hrs ago
137
RICK Deadline: RICK Investors Have Opportunity to Lead RCI Hospitality Holdings, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
Queens Chronicle
23 hrs ago
95
2025 World Internet Conference Wuzhen Summit Opens
Queens Chronicle
11/08
56
SanegeneBio Announces RNAi Licensing and Research Collaboration with Lilly
Queens Chronicle
11/08
36
iQIYI International Hosts iJOY 2026 Thailand in Bangkok, Unveiling Annual Content Strategy and New International Collaborations
Queens Chronicle
11/08
92
What to Know During Respiratory Virus Season
Queens Chronicle
11/08
98
Sharing Prosperity in the Intelligent Era: 2025 China International Intelligent Communication Forum Held in Wuxi
Queens Chronicle
11/08
53
Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer
Queens Chronicle
11/08
46
inne Debuts at CIIE with Global Launch of Two New Products
Queens Chronicle
11/08
16
SINA Investors Have Opportunity to Lead Sina Corporation Securities Fraud Lawsuit
Queens Chronicle
11/08
52
NX Investors Have Opportunity to Lead Quanex Building Products Corporation Securities Fraud Lawsuit
Queens Chronicle
11/08
47
U.S. FDA approves KYGEVVI™ (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)
Queens Chronicle
11/08
19
Lennar Announces Further Extension of Expiration Date of Exchange Offer
Queens Chronicle
11/07
107
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
Queens Chronicle
11/07
134
Rosen Law Firm Encourages America's Car-Mart, Inc. Investors to Inquire About Securities Class Action Investigation
Queens Chronicle
11/07
147
Boehringer awarded FDA Commissioner's National Priority Voucher for HERNEXEOS® in HER2 lung cancer
Queens Chronicle
11/07
93
WPP Investors Have Opportunity to Lead WPP plc Securities Fraud Lawsuit
Queens Chronicle
11/07
43
Michael J. Fox Foundation's "Parkinson's Podcast" Honored with Silver and Bronze Signal Awards
Queens Chronicle
11/07
29
VFC Deadline: VFC Investors have Opportunity to Lead V.F. Corporation Securities Fraud Lawsuit
Queens Chronicle
11/07
54
Meet the U.S. Army Soldier-athletes on a mission to compete for gold at the 2026 Winter Olympics
Queens Chronicle
11/07
6
Healthcare Therapy Services, Inc. Notifies Patients of Data Security Incident
Queens Chronicle
11/07
28
Lument Finance Trust Announces Quarter-End Earnings Release and Investor Call Dates
Queens Chronicle
11/07
132
Rosen Law Firm Encourages Nidec Corporation Investors to Inquire About Securities Class Action Investigation
Queens Chronicle
11/07
134
Beyond the diagnosis: What people with diabetes wish you knew
Queens Chronicle
11/07
116
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation
Queens Chronicle
11/07
119
Halper Sadeh LLC Encourages FSFG, WOW, FITB Shareholders to Contact the Firm to Discuss Their Rights
Queens Chronicle
11/07
127
Queens Chronicle